Doramic Tablet
Composition: Mefenamic Acid BP 250 mg + Drotaverine Hydrochloride 80 mg
Family:
Non-Steroidal Anti-Inflammatory Drug (NSAID) + Antispasmodic.
Product Description:
Doramic Tablet combines Mefenamic Acid, a non-steroidal anti-inflammatory medicine that helps relieve pain and inflammation, with Drotaverine Hydrochloride, an antispasmodic that relaxes smooth muscles and helps reduce painful spasms. This combination is designed to provide relief from pain associated with smooth-muscle spasms, particularly menstrual cramps, when appropriate for the patient.
Indications:
- Primary dysmenorrhea (painful menstrual cramps).
- Abdominal pain associated with smooth-muscle spasms.
- Spasmodic pain of selected gastrointestinal or urinary tract conditions, as prescribed.
- Other conditions requiring both analgesic and antispasmodic treatment, following clinical assessment.
Clinical Benefits:
- Helps relieve pain and inflammation.
- Relaxes smooth muscles to reduce spasms and cramping.
- Provides combined analgesic and antispasmodic action.
- May improve comfort and daily functioning during painful menstrual periods.
Dosage:
Each tablet contains Mefenamic Acid BP 250 mg and Drotaverine Hydrochloride 80 mg. The dose and duration should be determined by a healthcare professional according to the patient’s condition and the product’s approved labeling. Use the lowest effective dose for the shortest appropriate duration. Do not exceed the recommended dose.
Contraindications:
Contraindicated in patients with known allergy to either ingredient, active peptic ulcer or gastrointestinal bleeding, severe kidney or liver impairment, or severe heart failure. Avoid in patients with a history of NSAID-induced asthma or allergic reactions to aspirin and other NSAIDs. Avoid Mefenamic Acid during the third trimester of pregnancy.
Side Effects:
Possible side effects include nausea, abdominal discomfort, diarrhea, dizziness, headache, and low blood pressure. Serious risks associated with Mefenamic Acid include gastrointestinal bleeding, kidney injury, and allergic reactions.
Usage in Pregnancy:
Use during pregnancy only under medical supervision. Mefenamic Acid should generally be avoided from 20 weeks of pregnancy unless specifically advised by a healthcare professional and avoided from 30 weeks onward. Seek professional advice before use while breastfeeding.
Interactions:
- Other NSAIDs, aspirin, and anticoagulants may increase the risk of bleeding.
- Corticosteroids may increase the risk of gastrointestinal ulcers and bleeding.
- Diuretics and certain blood-pressure medicines may have increased kidney-related risks when used with Mefenamic Acid.
- Review all concurrent medicines with a healthcare professional before use.
Administration:
Take according to the prescribed instructions. Do not combine with other NSAIDs unless specifically advised by a healthcare professional.
Company: UNIMAX